Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

US Patent Office Issues New Transplant Patent to CareDx

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  CareDx, Inc.

Daré Bioscience Completes Recruitment in Pre-Pivotal Trial Of Monthly Woman-Controlled, Hormone-Free Contraceptive Candidate, Ovaprene®

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Daré Bioscience, Inc.

Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement with ChemImage to Expand Personalized Medicine to Prostate Cancer Prognosis and Treatment

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

BioSyent Announces Withdrawal of Health Canada Submissions for Cardiovascular Products

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  BioSyent Inc.

Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Cambrex Corporation

Aptinyx Presents Preclinical Data Demonstrating Robust Activity of NYX-783 on Alcohol-Seeking Behavior and Relapse-Like Behavior in Multiple Models of Alcohol Use Disorder

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Aptinyx Inc.

Acasti Pharma Provides Fiscal 2019 Year-End Business Update

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Acasti Pharma, Inc.

XBiotech Wins “Commercial Real Estate Award for Industrial Development” for its Headquarters in Austin, Texas

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  XBiotech Inc.

CorMedix Inc. Set to Join the Russell 2000® Index

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  CorMedix Inc.

Letter to Shareholders from Curt Fairbrother, CEO

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo® (nivolumab) Phase 1 Combination Trial in Brain Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  ZIOPHARM Oncology, Inc.

Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Global Blood Therapeutics Inc.

Golden Leaf Holdings Ltd. Announces Election of New Board of Directors, Approval of Amendment to Terms of Debenture Indenture for Debentures Maturing November 2, 2019 and Release of Slide Presentation

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

Y-mAbs Announces Data to be Presented at 2019 SIOP

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Y-mAbs Therapeutics, Inc

Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen Wound Conforming Matrix

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Generex Biotechnology Corp. | Genovior Biotech Corporation

BioPorto Appoints New Chief Medical Officer

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  BioPorto Diagnostics A/S

Fagron NV: Fagron reaches settlement in principle with US Department of Justice

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

Copeland Biosciences Corp. Retains KCSA Strategic Communications as Corporate Communications Counsel

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

OmniSeq Board Names Margot Schoenborn to Succeed Mark Gardner as CEO

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  OmniSeq, LLC

HydraFacial MD® Now Available with Dr. Samuel Hahn

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Plastic Surgery Hospital (Institute), CAMS, PUMC | Galardi-Rosenblum Plastic Surgery
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑